$68.78 -0.22 (%) Astrazeneca Shs Sponsored American Deposit Receipt Repr 1 Sh - NYSE

Oct. 22, 2014 | 04:00 PM

Partner Headlines

  1. Celgene, Alexion Among 4 IBD 50 Medical s To Report

    IBD | Oct. 18, 2014 | 08:02AM EST
  2. Illumina Helps Make Gene Sequencing Affordable

    IBD | Oct. 17, 2014 | 18:48PM EST
  3. Shire Falls, AbbVie Questioned On Buyout Backtrack

    IBD | Oct. 15, 2014 | 13:11PM EST
  4. Illumina Pads Gene Sequencing Lead With Pharma Deals

    IBD | Oct. 8, 2014 | 16:04PM EST
  5. Actavis, Jazz, Novo Lead Top World Stocks List

    IBD | Oct. 7, 2014 | 18:08PM EST
  6. Actavis rival results positive

    IBD | Oct. 1, 2014 | 18:43PM EST
  7. Ardelyx Bowel Drug Could Rival Actavis' Linzess

    IBD | Oct. 1, 2014 | 12:10PM EST
  8. Tax Inversions Help Push Global M&A To 7-Year High

    IBD | Sep. 29, 2014 | 18:33PM EST
  9. A Few Reasons Why AbbVie's Momentum Will Continue

    GuruFocus | Sep. 25, 2014 | 17:53PM EST
  10. European Stocks Fall Most In 11 Weeks; CAC-40 Off 1.9%

    IBD | Sep. 23, 2014 | 18:48PM EST
  11. Benzinga's M&A Chatter for Tuesday September 23, 2014

    Benzinga | Sep. 23, 2014 | 18:35PM EST
  12. Inversions Thwarted, But Real Tax Fix Needs Congress

    IBD | Sep. 23, 2014 | 18:28PM EST
  13. Stocks Fall To Session Lows; Vipshop Bucks The Trend

    IBD | Sep. 23, 2014 | 15:00PM EST
  14. Pfizer Inc. Is Kicking The Tires At Actavis PLC

    Benzinga | Sep. 23, 2014 | 14:45PM EST
  15. Inversion Crackdown Leaves Several Deals In Limbo

    Benzinga | Sep. 23, 2014 | 12:41PM EST
  16. Midday Losers From September 23 - Alco Stores Inc, CarMax, Inc And More

    Benzinga | Sep. 23, 2014 | 12:37PM EST
  17. Markets Mixed; Carnival Profit Tops Street View

    Benzinga | Sep. 23, 2014 | 11:20AM EST
  18. Drug giants target Alzheimer's

    IBD | Sep. 16, 2014 | 18:49PM EST
  19. Salix, Gilead Among 5 Top Medical Leaders To Watch

    IBD | Sep. 5, 2014 | 17:06PM EST
  20. Merck PD-1 Inhibitor Approved For Skin Cancer

    IBD | Sep. 4, 2014 | 16:33PM EST
  21. Teva Announces UK High Court Gives Positive Judgment In The Company's Patent Case Against AstraZeneca

    Benzinga | Sep. 3, 2014 | 05:10AM EST
  22. SunTrust Sees Further Pfizer Inc. Bid For AstraZeneca PLC 'Highly Likely'

    Benzinga | Sep. 2, 2014 | 15:35PM EST
  23. AstraZeneca

    IBD | Aug. 29, 2014 | 18:54PM EST
  24. Deutsche Bank Says Pfizer Has A Strong Financial Position And Attractive Pipeline

    Benzinga | Aug. 27, 2014 | 11:25AM EST
  25. Gilead, Jazz Among 4 Top Big Cap Medicals To Watch

    IBD | Aug. 27, 2014 | 08:02AM EST
  26. Merck, Pfizer Combining Drugs In Lung Cancer Study

    IBD | Aug. 26, 2014 | 12:07PM EST
  27. The 4 Companies Teaming Up For A New Tool To Fight Cancer

    Benzinga | Aug. 25, 2014 | 16:03PM EST
  28. Illumina lines up key partners

    IBD | Aug. 21, 2014 | 18:41PM EST
  29. Markets Continue To Rally Ahead Of Yellen's Speech At Jackson Hole

    Benzinga | Aug. 21, 2014 | 17:16PM EST
  30. Illumina Forms Partnerships With Big Pharma Firms

    IBD | Aug. 21, 2014 | 12:03PM EST
  31. Pfizer Could Revive AstraZeneca Bid As Early As Tuesday

    Benzinga | Aug. 21, 2014 | 11:39AM EST
  32. Stocks Open Higher, Turn Mixed; Illumina Rises, Autohome Slips

    IBD | Aug. 21, 2014 | 10:35AM EST
  33. Treasury Develolping Options to Curb Inversions

    FoxBusiness | Aug. 18, 2014 | 13:34PM EST
  34. Walgreen Leads Sell-Off In 'Tax Inversion' Stocks

    IBD | Aug. 6, 2014 | 10:15AM EST
  35. Drugmaker AstraZeneca Returns To Growth

    IBD | Aug. 5, 2014 | 17:22PM EST
  36. Walgreen Names New CFO Ahead of Possible Inversion

    IBD | Aug. 4, 2014 | 12:29PM EST
  37. Steven Cohen Has a Track Record of Impressive Returns

    GuruFocus | Jul. 31, 2014 | 11:18AM EST
  38. Stocks Mixed Despite Better-Than-Expected GDP

    Benzinga | Jul. 30, 2014 | 16:43PM EST
  39. Citigroup Comments On Potential Pfizer/AstraZeneca Acquisition

    Benzinga | Jul. 29, 2014 | 11:49AM EST
  40. Merck, Pfizer Beat Q2 Earnings Estimates

    IBD | Jul. 29, 2014 | 11:23AM EST
  41. Pfizer, Merck, Amgen Near Q2 Earnings Reports

    IBD | Jul. 28, 2014 | 13:02PM EST
  42. Horizon Pharma Drugs Ditched By Pharmacies; Stock Falls

    IBD | Jul. 28, 2014 | 11:14AM EST
  43. Benzinga Weekly Preview: FOMC In Focus, As Earnings Season Progresses

    Benzinga | Jul. 26, 2014 | 13:58PM EST
  44. FT: 25 More Firms May Seek Tax Breaks Overseas

    FoxBusiness | Jul. 22, 2014 | 16:59PM EST
  45. Will Congress Scuttle the AbbVie-Shire Merger?

    FoxBusiness | Jul. 18, 2014 | 13:23PM EST
  46. I Believe AstraZeneca Is Fairly Valued

    GuruFocus | Jul. 16, 2014 | 11:35AM EST
  47. Walgreen Tax Inversion: Masking A Weak Business?

    YCharts | Jul. 11, 2014 | 19:34PM EST
  48. British Blue Chips Beckon

    Benzinga | Jul. 11, 2014 | 09:20AM EST
  49. Top 4 NYSE Stocks In The Drug Manufacturers-Major Industry With The Highest Dividend Yield

    Benzinga | Jul. 11, 2014 | 04:14AM EST
  50. In Pursuit of Shire, AbbVie Eyes Lower Taxes in UK

    FoxBusiness | Jul. 8, 2014 | 13:20PM EST
Trading Center